Core Viewpoint - Hualan Co., Ltd. has signed a share transfer agreement to acquire a 35% stake in Ningbo Guangfeng Capsule Co., Ltd. from Ningbo Spokan Biotechnology Co., Ltd. for RMB 8.4647 million, with plans to increase its ownership to between 51% and 70% by 2028 [1] Group 1 - Hualan Co., Ltd. will use its own funds to purchase a 35% stake in Guangfeng Capsule, with the transaction expected to enhance its control over the company [1] - The agreement allows Hualan to further acquire an additional 16% to 35% of Guangfeng's shares between 2026 and 2028, potentially increasing its stake to a controlling interest [1] - Guangfeng Capsule specializes in the manufacturing and sales of hollow capsules, with its core product, gelatin hollow capsules, having passed technical review by the National Medical Products Administration [1] Group 2 - The completion of this transaction will enable Hualan to share customer resources with Guangfeng, leveraging its compliance management capabilities and quality control systems to enhance product quality and expand business scale [1]
华兰股份(301093.SZ)拟取得广峰胶囊35%股权 其主营空心胶囊相关业务